Designing PDT-based combinations to overcome chemoresistance in heterocellular 3D tumor models
(Conference Presentation)

Imran Rizvi; Emma A. Briars; Anne-Laure Bulin; Sriram Anbil; Daniela Vecchio; Ahmed Alkhateeb; William R. Hanna; Jonathan P. Celli; Tayyaba Hasan

doi:10.1117/12.2213436

26 April 2016 Designing PDT-based combinations to overcome chemoresistance in heterocellular 3D tumor models (Conference Presentation)

Imran Rizvi, Emma A. Briars, Anne-Laure Bulin, Sriram Anbil, Daniela Vecchio, Ahmed Alkhateeb, William R. Hanna, Jonathan P. Celli, Tayyaba Hasan

Author Affiliations +

Proceedings Volume 9694, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXV; 969404 (2016) https://doi.org/10.1117/12.2213436
Event: SPIE BiOS, 2016, San Francisco, California, United States

Abstract

A major barrier to treating advanced-stage cancers is heterogeneity in the responsiveness of metastatic disease to conventional therapies leading to resistance and treatment failure. Photodynamic therapy (PDT) has been shown to synergize with conventional agents and to overcome the evasion pathways that cause resistance. Developing PDT-based combinations that target resistant tumor populations and cooperate mechanistically with conventional agents is an increasingly promising approach to improve therapeutic efficacy while minimizing toxicity, particularly in complex disease sites. Identifying the molecular, cellular, and microenvironmental cues that lead to heterogeneity and treatment resistance is critical to developing strategies to target unresponsive regions of stubborn disease. Cell-based research platforms that integrate key microenvironmental cues are emerging as increasingly important tools to improve the translational efficiency of new agents, and to design combination regimens. Among the challenges associated with developing and scaling complex cell-based screening platforms is the need to integrate, and balance, biological relevance with appropriate, high-content imaging routines that provide meaningful quantitative readouts of therapeutic response. The benefits and challenges associated with deriving meaningful insights from complex cell-based models will be presented, with a particular emphasis on overcoming chemoresistance mediated by physical stress and communication with stromal partners (e.g. tumor endothelial cells, which are emerging as dynamic regulators of treatment resistance) using PDT-based combinations.

Conference Presentation

Citation Download Citation

Imran Rizvi, Emma A. Briars, Anne-Laure Bulin, Sriram Anbil, Daniela Vecchio, Ahmed Alkhateeb, William R. Hanna, Jonathan P. Celli, and Tayyaba Hasan "Designing PDT-based combinations to overcome chemoresistance in heterocellular 3D tumor models (Conference Presentation)", Proc. SPIE 9694, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXV, 969404 (26 April 2016); https://doi.org/10.1117/12.2213436

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available

Members: $17.00

Non-members: $21.00 ADD TO CART

PROCEEDINGS
PRESENTATION

WATCH
PRESENTATION SAVE TO MY LIBRARY

GET CITATION

KEYWORDS

3D modeling

Resistance

Tumors

Photodynamic therapy

Cancer

Oncology

Photomedicine

Show All Keywords

Keywords/Phrases

Search In:

Publication Years